Literature DB >> 29929995

Prenatal Antidepressant Exposure and Child Motor Development: A Meta-analysis.

Katherine Grove1, Andrew J Lewis2, Megan Galbally3,4,5.   

Abstract

CONTEXT: There is increasing use of antidepressants in pregnancy and hence children exposed in utero. Contradictory studies exist in the literature in which researchers report on the potential impact of antenatal antidepressant exposure on subsequent child motor development.
OBJECTIVE: Our objective in this systematic review and meta-analysis was to determine whether antenatal antidepressant exposure increases the risk of impaired motor development in children. DATA SOURCES: We searched PsychINFO, Embase, Medline, PubMed, and Scopus up to July 24, 2017. STUDY SELECTION: English-language cohort and case control studies in which researchers report primary data from a motor assessment of infants or children after any antidepressant exposure in pregnancy were included. DATA EXTRACTION: Of the 329 studies identified, there were 160 articles screened, 24 were included in the systematic review, and 18 met inclusion criteria for the meta-analysis.
RESULTS: The total pooled results were based on random effects models and revealed a significant association between exposure to antidepressants during pregnancy and overall occurrence of poorer motor outcomes in children (effect size = 0.22; 95% confidence interval = 0.07 to 0.37) with a moderate degree of heterogeneity (I2 = 56.6%). LIMITATIONS: There was variation in the measurement both of exposure and motor development across the identified study, and few followed up to later childhood or beyond.
CONCLUSIONS: A small increased risk of poorer motor development may exist for children who are exposed to antidepressant medications during pregnancy. However, the marked methodological variation among studies and the limited control for possible confounds warrants cautious interpretation of these findings.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29929995     DOI: 10.1542/peds.2018-0356

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  How clinicians can support women in making decisions about psychopharmacological treatments in pregnancy.

Authors:  Megan Galbally; Nicole Woods; Martien Snellen
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

2.  Antidepressant use during pregnancy and risk of adverse neonatal outcomes: A comprehensive investigation of previously identified associations.

Authors:  Anna-Sophie Rommel; Natalie C Momen; Nina Maren Molenaar; Esben Agerbo; Veerle Bergink; Trine Munk-Olsen; Xiaoqin Liu
Journal:  Acta Psychiatr Scand       Date:  2022-02-18       Impact factor: 7.734

3.  Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.

Authors:  Anna-Sophie Rommel; Veerle Bergink; Xiaoqin Liu; Trine Munk-Olsen; Nina Maren Molenaar
Journal:  J Clin Psychiatry       Date:  2020-05-12       Impact factor: 4.384

4.  Antidepressant Use During Pregnancy and the Potential Risks of Motor Outcomes and Intellectual Disabilities in Offspring: A Systematic Review.

Authors:  Nouf Al-Fadel; Adel Alrwisan
Journal:  Drugs Real World Outcomes       Date:  2021-02-12

Review 5.  Role of Serotoninergic Antidepressants in the Development of Autism Spectrum Disorders: A Systematic Review.

Authors:  Sheena Mathew; Sumahitha Bichenapally; Vahe Khachatryan; Asmaa Muazzam; Chandani Hamal; Lakshmi Sai Deepak Reddy Velugoti; Godfrey Tabowei; Greeshma N Gaddipati; Maria Mukhtar; Mohammed J Alzubaidee; Raga Sruthi Dwarampudi; Michael Alfonso
Journal:  Cureus       Date:  2022-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.